|
Aaron I. Davis
|
Director |
|
Ann D Rhoads
|
Director |
|
Ansbert Gadicke
|
10% or greater ownership |
|
Asset Management Inc. Boxer
|
See remarks |
|
Asset Management Investors Bv2014 Llc Mpm
|
10% or greater ownership |
|
Asset Management Investors Bv2018 Llc Mpm
|
10% or greater ownership |
|
Bioventures 2014 (b), L.p. Mpm
|
10% or greater ownership |
|
Bioventures 2014 Gp Llc Mpm
|
10% or greater ownership |
|
Bioventures 2014 Llc Mpm
|
10% or greater ownership |
|
Bioventures 2014, L.p. Mpm
|
10% or greater ownership |
|
Bioventures 2018 (b), L.p. Mpm
|
10% or greater ownership |
|
Bioventures 2018 Gp Llc Mpm
|
10% or greater ownership |
|
Bioventures 2018 Llc Mpm
|
10% or greater ownership |
|
Bioventures 2018, L.p. Mpm
|
10% or greater ownership |
|
Capital Healthcare Fund Lp Ra
|
Former 10% Owner |
|
Capital Llc Bioimpact
|
10% or greater ownership |
|
Capital Management, L.p. Ra
|
Former 10% Owner |
|
Capital, Llc Boxer
|
See remarks |
|
David Feltquate
|
Chief Medical Officer |
|
David Hallal
|
Director |
|
David K Lee
|
Director |
|
Derek Dirocco
|
Director |
|
Detlev Biniszkiewicz
|
Director |
|
Hauwermeiren Timothy Van
|
Director |
|
Impact Fund (cayman) Management L.p. Oncology
|
10% or greater ownership |
|
Jill Desimone
|
Director |
|
Joanne Jenkins Lager
|
Chief Medical Officer |
|
Joseph Lewis
|
See remarks |
|
Luke Evnin
|
10% or greater ownership |
|
Matthew Call
|
Chief Operating Officer |
|
Matthew Gall
|
Chief Financial Officer |
|
Matthew Roden
|
Director |
|
Michel Detheux
|
Chief Executive Officer |
|
Oncology Impact Fund L.p. Ubs
|
10% or greater ownership |
|
Peter Kolchinsky
|
Former 10% Owner |
|
Rajeev M. Shah
|
Former 10% Owner |
|
Robert Iannone
|
Director |
|
Todd Foley
|
10% or greater ownership |
|
Tony W Ho
|
Director |
|
Yvonne Mcgrath
|
Chief Scientific Officer |
